Detalhe da pesquisa
1.
Randomized controlled trial of a gluten-free diet in patients with schizophrenia positive for antigliadin antibodies (AGA IgG): a pilot feasibility study
J Psychiatry Neurosci
; 44(4): 269-276, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30938127
2.
Adjunct Aripiprazole Reduces Prolactin and Prolactin-Related Adverse Effects in Premenopausal Women With Psychosis: Results From the DAAMSEL Clinical Trial.
J Clin Psychopharmacol
; 38(4): 317-326, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29912799
3.
Adjunctive Minocycline in Clozapine-Treated Patients with Schizophrenia: Analyzing the Effects of Minocycline on Clozapine Plasma Levels.
Psychiatr Q
; 89(1): 73-80, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28466366
4.
A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia.
J Clin Psychopharmacol
; 37(4): 394-400, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28590362
5.
Antipsychotic Treatment and Tobacco Craving in People With Schizophrenia.
J Dual Diagn
; 13(1): 36-42, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28166471
6.
Reduced kynurenine pathway metabolism and cytokine expression in the prefrontal cortex of depressed individuals.
J Psychiatry Neurosci
; 41(6): 386-394, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27070351
7.
Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms.
J Clin Psychopharmacol
; 35(4): 374-81, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26082974
8.
Urine testing for antipsychotics: a pilot trial for a method to determine detection levels.
Hum Psychopharmacol
; 30(5): 350-5, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26010339
9.
Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin).
BMC Psychiatry
; 13: 214, 2013 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-23968123
10.
Antagonist-elicited cannabis withdrawal in humans.
J Clin Psychopharmacol
; 31(5): 603-12, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21869692
11.
Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study.
J Clin Psychopharmacol
; 31(1): 86-91, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21192149
12.
A Randomized Clinical Trial of Oxytocin or Galantamine in Schizophrenia: Assessing the Impact on Behavioral, Lexical, and Self-Report Indicators of Social Affiliation.
Schizophr Bull Open
; 1(1): sgaa001, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32803156
13.
The characteristics of cognitive neuroscience tests in a schizophrenia cognition clinical trial: Psychometric properties and correlations with standard measures.
Schizophr Res Cogn
; 19: 100161, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31832342
14.
Cardiac-related findings at autopsy in people with severe mental illness treated with clozapine or risperidone.
Schizophr Res
; 107(2-3): 134-8, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19028422
15.
Impaired visual working memory consolidation in schizophrenia.
Neuropsychology
; 23(1): 71-80, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19210034
16.
Dopamine transporter polymorphism modulates oculomotor function and DAT1 mRNA expression in schizophrenia.
Am J Med Genet B Neuropsychiatr Genet
; 150B(2): 282-9, 2009 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-18553389
17.
The Effect of Intranasal Oxytocin on Measures of Social Cognition in Schizophrenia: A Negative Report.
J Psychiatr Brain Sci
; 4(1)2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31037274
18.
Galantamine for the treatment of cognitive impairments in people with schizophrenia.
Am J Psychiatry
; 165(1): 82-9, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17986678
19.
Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia.
Schizophr Res
; 103(1-3): 161-8, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18550339
20.
Effects of the cannabinoid-1 receptor antagonist/inverse agonist rimonabant on satiety signaling in overweight people with schizophrenia: a randomized, double-blind, pilot study.
J Clin Psychopharmacol
; 33(1): 118-20, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23277241